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osting by EAbstract The association of hyperuricemia with increased risk of atherosclerosis has been reported
in previous studies but the link of acute gouty arthritis, hyperuricemia and acute myocardial infarc-
tion (MI) is not seen frequently. Here we report a 33 year old male who presented with hyperuri-
cemia, acute gouty arthritis and acute myocardial infarction. Hyperuricemia contributed not
only to accelerated atherosclerosis but might be blamed for promoting environment for acute
myocardial infarction.
ª 2010 King Saud University. All rights reserved.1. Introduction
For the occurrence of acute myocardial infarction (MI), an
environment that promotes atherogenesis and thrombogenesis
is needed. Hyperuricemia is well known to be an independent
risk factor for atherosclerotic diseases in general (Culleton
et al., 1999; Benedek, 1967). Furthermore, the link between
gout and atherosclerosis has been observed for more than
100 years (Janessens et al., 2003; Abbott et al., 1988). How-
ever, the link between acute gouty arthritis and acute MI, isniversity, P.O. Box 40294, Al-
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lsevierscarcely reported. Here we report a case of acute MI with
the ﬁrst presentation of acute gouty arthritis.
2. Case presentation
A 33-year-old male patient with no previous medical illnesses
presented to the Emergency Department with acute onset
crushing retrosternal chest pain of 1 hour duration with evi-
dence of ST-elevation extending from V1 to V5 on his initial
electrocardiogram. His past medical history was unremark-
able. On physical examination: weight: 63 kg, height: 165 cm
with BMI of 22.8 kg/m2, blood pressure: 110/70 mmHg with
unremarkable cardiovascular exam. Troponin peak at 62 ng/
ml and CK at 1360 mg/dl, FBS: 89 mg/dl, lipid proﬁle: LDL
93 mg/dl, HDL: 35 mg/dl, TG: 143 mg/dl with normal urea,
creatinine and complete blood count. He was transferred to
the catheterization lab and underwent successful primary per-
cutaneous intervention (PCI) with stenting of long mid left
anterior descending artery (LAD) lesion with two drug eluting
stents (Cypher plus) (Figs. 1 and 2). There were no critical
lesions of other major epicardial vessels. A total of 128 ml of
nonionic contrast was used for the procedure. Post PCI, the
Figure 1 Coronary angiogram showing critical proximal LAD
lesion. Figure 3 AP and lateral X-ray right ankle with soft tissue
swelling.
146 A.M. Alshehripatient was started on aspirin 81 mg, clopidogrel 75 mg, biso-
prolol 5 mg, lisinopril 2.5 mg and lipitor 20 mg in addition to
tiroﬁban infusion. One day later he had severe pain associated
with swelling and erythema of his right ankle joint. X-ray of
the joint demonstrated soft tissue swelling (Fig. 3). Serum uric
acid was found to be signiﬁcantly elevated at 12 mg/dl. Diag-
nosis of acute gouty arthritis has been made and the patient
was started on IV diclofenac with prompt resolution of the
pain and the ankle swelling within 2 days of initiating the ther-
apy. However, our patient had none of the risk factors for cor-
onary artery disease (CAD). He was not known to be diabetic,
hypertensive, smoker or dyslipidemic and his family history is
negative for CAD.
3. Discussion
The association between gout and atherosclerosis has been
noted for a century (Janessens et al., 2003; Abbott et al.,
1988). While most studies could not demonstrate an increased
risk for CAD by serum urate level, most authors attribute the
association between gout and CAD to the confounding effects
of coexistent disorders, such as hypertension, diabetes, or
hyperlipidemia (Abbott et al., 1988). Our patient, however,Figure 2 Coronary angiogram showing the LAD lesion after
stenting.was not having any of these confounders and yet he had signif-
icant coronary atherosclerosis complicated by an acute
myocardial infarction (MI). His serum urate level was signiﬁ-
cantly elevated and associated with acute gouty arthritis. This
suggests that hyperuricemia might not only be involved in pre-
disposing to coronary atherosclerosis, but also to the possible
association with acute MI.
When chronic and/or severe hyperuricemia leads to the pre-
cipitation of urate crystals within joints, it results in an inﬂam-
matory response that manifests as gouty arthritis. The
inﬂammatory activity associated with gout can itself be pro-
atherogenic and promote a prothrombotic environment that
leads to acute coronary events (Tiong and Brieger, 2005). So
serum uric acid may be involved in platelet adhesiveness,
aggregation, or inﬂammation and may be implicated in the
genesis of acute MI (Ask-Upmark and Adner, 1950; Wannam-
ethee et al., 1997; Krishnan et al., 2006). In a single retrospec-
tive study, Krishnan et al. demonstrated that gout is associated
with increased risk of Q-wave MI and both the severity of
gouty arthritis and the serum urate level are independent pre-
dictors for such an association (Krishnan et al., 2006).
4. Conclusion
Our case represent a good example of the possible link between
acute MI, hyperuricemia and acute gouty arthritis. This may
suggests the need for further well conducted studies to establish
the magnitude and the possible mechanism by which hyperuri-
cemia increased the risk of acute coronary events. In addition,
whether lowering the serum urate level per se can lower the risk
of having atherosclerosis and acute MI in patients with gouty
arthritis remained as an unanswered question (?).
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